Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2007
12/11/2007US7307163 Process for the preparation of linezolid and related compounds
12/11/2007US7307095 Osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis, (S)-2-(Benzooxazol-2-ylamino)-3-cyclohexyl-N-[2-(5-fluoro-2,3-dihydro-indol-1-yl)-ethyl]-propionamide
12/11/2007US7307088 Substituted anthranilic amide derivatives and methods of use
12/11/2007US7307086 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/11/2007US7307077 Heterocyclic compound and antitumor agent containing the same as effective ingredient
12/11/2007US7307075 Tetrahydroquinoline analogues as muscarinic agonists
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007140005A2 Oxazolyl piperidine modulators of fatty acid amide hydrolase
12/06/2007WO2007139413A2 Polymorphs of (r) -5- (2-aminoethyl) -1- (6, 8-difluorochroman-3-yl) -1,3- dihydroimidazole-thione hydrochloride
12/06/2007WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof
12/06/2007WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound
12/06/2007WO2007138994A1 Hsp90 inhibitor
12/06/2007WO2007138033A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands
12/06/2007WO2007137980A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007WO2007137954A1 Aryl-4-ethynyl-isoxazole derivatives
12/06/2007WO2007137792A1 Substituted heterocycles and use thereof
12/06/2007WO2007137462A1 A acryloylmorpholine, process for preparation thereof and its use
12/06/2007WO2007137417A1 Heterocyclic compounds as calcium channel blockers
12/06/2007WO2007110727A3 Amide stabilized hydroxyethylamines
12/06/2007WO2007109456A3 Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists
12/06/2007WO2007105053A3 Tetralines antagonists of the h-3 receptor
12/06/2007WO2007079186A3 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors
12/06/2007WO2007061695A3 Bicyclic spirohydantoin cgrp receptor antagonists
12/06/2007WO2006106427A8 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
12/06/2007WO2006067428A3 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands
12/06/2007US20070282101 Indazole compounds
12/06/2007US20070281980 Polymorphic forms of (S). -tetrahydrofuran-3-yl-3- (3- (3-methoxy-4- (oxazol-5-yl) pheny1) ureido) benzylcarbamate
12/06/2007US20070281946 Tri(cyclo) substituted amide compounds
12/06/2007US20070281945 Benzoxazole and benzothiazole derivatives as 5-hydroxytryptamine-6 ligands
12/06/2007US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1
12/06/2007US20070281936 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide
12/06/2007US20070281934 Indole derivatives as inhibitors of histone deacetylase
12/06/2007US20070281932 Method of preparing 4-halogenated quinoline intermediates
12/06/2007US20070281930 bicyclic bisamides for controlling acarina
12/06/2007US20070281928 Fused Ring Azadecalin Glucocorticoid Receptor Modulators
12/06/2007US20070281921 Piperidinyl pyrimidine derivatives
12/06/2007US20070281920 5-(1H-indol-5-yl)-2-methyl-2,3,4,5-tetrahydro-1H-benzo[c]azepine; for treatment of monoamine reuptake inhibitor-mediated diseases such as depression, anxiety, genitourinary disorders and pain
12/06/2007US20070281916 Substituted isoxazolines and their use as antibacterial agents
12/06/2007US20070278461 Photochromic materials comprising haloalkyl groups
12/06/2007DE102006025319A1 Substituierte Heterozyklen und ihre Verwendung Substituted heterocycles and their use
12/06/2007DE102006025317A1 Isoindolin-1-on-,Isoindolin-3-on und Isoindolin-1,3-dion-Derivate und ihre Verwendung Isoindoline-1-one, isoindoline-3-one and isoindoline-1,3-dione derivatives and their use
12/06/2007DE102006025316A1 Isoindolin-1-on-, Isoindolin-3-on- und Isoindolin-1,3-dion-Derivate und ihre Verwendung Isoindoline-1-one, isoindoline-3-one and isoindoline-1,3-dione derivatives and their use
12/06/2007DE102006025314A1 Arylsubstituierte Heterozyklen und ihre Verwendung Aryl-substituted heterocycles and their use
12/06/2007CA2653956A1 New crystal forms
12/06/2007CA2653771A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands
12/06/2007CA2653670A1 Substituted heterocycles and their use
12/06/2007CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof
12/06/2007CA2653497A1 Heterocyclic compounds as calcium channel blockers
12/06/2007CA2653329A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2653319A1 Hsp90 inhibitor
12/06/2007CA2652636A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007CA2651857A1 Aryl-4-ethynyl-isoxazole derivatives
12/05/2007EP1862458A2 Therapeutic agents useful for treating pain
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1861394A1 Substituted pyridine derivatives
12/05/2007EP1861393A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/05/2007EP1861382A1 Fused aromatic compounds having anti-diabetic activity
12/05/2007EP1861377A1 Benzimidazolone derivatives as cb2 receptor ligands
12/05/2007EP1861376A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
12/05/2007EP1861372A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
12/05/2007EP1861371A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase.
12/05/2007EP1861370A1 2-pyridine derivatives as inhibitors of neutrophile elastase
12/05/2007EP1861365A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
12/05/2007EP1860942A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/05/2007EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007EP1208085B1 Benzanilides as potassium channel openers
12/05/2007EP1137642B1 Bis-sulfonamides
12/05/2007CN101084203A New 3-phenylpropionic acid derivatives for the treatment of diabetes
12/05/2007CN101084198A Substituted amino-pyrimidones and uses thereof
12/05/2007CN101084195A 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
12/05/2007CN101083988A 有丝分裂驱动蛋白抑制剂及其使用方法 Mitotic kinesin inhibitors and methods of use
12/05/2007CN101081843A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
12/05/2007CN100352816C Nociceptin analogs
12/05/2007CN100352808C Heterocyclic diamide invertebrate pest control agents
12/05/2007CN100352807C Chemical compounds
12/05/2007CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/05/2007CN100352443C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/04/2007US7304162 Regulating and tailoring expression levels; such as N-[3-(4-chloro-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-3-ethyl-benzamide
12/04/2007US7304160 intermediates for enantiomerically pure analogs having silyl or alkyl groups at C4 position; organometallic nucleophile or Grignard and an silyl or alkyl acyl halide reacted with nicotine; oxidation and deacylation to 4-hydroxy; modulate nicotinic acetylcholine receptors; Alzheimer's, Parkinson's
12/04/2007US7304158 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide
12/04/2007US7304087 1-acyl-pyrrolidine derivatives for the treatment of viral infections
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304080 Substituted 1,2,4-oxadiazoles, compositions and methods of use
12/04/2007US7304077 Asthma, rhinitis therapy
12/04/2007US7304063 Inhibitors of Akt activity
12/04/2007US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304058 For therapy of Alzheimer's disease, depression
12/04/2007US7304052 Irritable bowel syndrome; gastrointestinal disorders
12/04/2007US7304051 Quinoxaline compounds
12/04/2007US7304050 Antibacterial agents
12/04/2007US7303871 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating damaging effects of gluten
12/04/2007CA2424964C Nitrogen-containing 5-membered ring compound
12/04/2007CA2337800C Farnesyl protein transferase inhibitors for treating arthropathies
12/04/2007CA2227039C One pot synthesis of 2-oxazolidinone derivatives
11/2007
11/29/2007WO2007136703A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007WO2007136680A2 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto